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1. Introduction  
Strongyloidiasis is an intestinal parasitosis found in tropical and subtropical areas, where 
the warm climates are suitable for parasite survival (Barr, 1978). It is a common cause of 
morbidity and mortality, particularly in developing countries, and infects over one-quarter 
of the world’s population (Genta, 1989). Approximately 52 species are known to infect 
mammals, birds, reptiles and amphibians (Speare, 1989). The most common globally 
distributed human pathogen of clinical importance is Strongyloides stercoralis (Schad, 1989). 
Another species, Strongyloides fuelleborni, is a zoonotic parasite that infects primates and is 
found sporadically in humans in Africa (Pampiglione & Ricciardi, 1972). S. stercoralis is a 
ubiquitous soil-transmitted intestinal nematode that was first reported in 1876 in French 
soldiers working in Vietnam. It is unique among helminths in that it completes its life cycle 
inside a single human host. A unique feature of strongyloidiasis is the ability of the parasite to 
autoinfect the host, which makes S. stercoralis a significant public health problem (Grove, 1989). 
2. Epidemiology 
The epidemiology of Strongyloides infection is poorly understood because it is difficult to 
detect and can be underestimated (Albonico et al., 1999; Viney & Lok, 2007). However, it is 
estimated that from 30 a 100 million people are infected worldwide with Strongyloides, and 
can range from asymptomic to multiorgan failure (Genta, 1989). Strongyloides is found in 
tropical and subtropical areas and requires specific soil and climate conditions for its 
development. In North America, Latin America, Africa and Southeast Asia, the infection is 
endemic (Roxby et al., 2009). The risk of acquiring strongyloidiasis is higher in rural areas, 
among people who work with soil, and among lower socioeconomic groups (Vadlamudi et 
al., 2006; Viney & Lok, 2007). Walking barefoot in areas where human faeces containing the 
parasite are deposited increases the probability of acquiring the infection (Grove, 1994).  
3. Parasite 
S. stercoralis has free-living and parasitic life cycles, and the morphology of each differs. 
Parasitic worms are female adults that reproduce by parthenogenesis and measure 
approximately 1 - 10 mm in length by 27 -95 μm in width. Free-living adults are 
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approximately 1 mm, live in the soil, and reproduce sexually; females are slightly larger 
than males (Speare, 1989). Embryonated eggs are thin-shelled and measure approximately 
55 - 60 μm in length and 28 - 32 μm in width. Rhabditiform larvae are the first-stage larvae 
(210 μm) and develop into free-living larvae or third-stage infective larvae that measure 
approximately 490-630 μm and are capable of infecting the host (Schad, 1989). 
4. Life cycle 
The life cycle of S. stercoralis includes a parasitic cycle (within human hosts) and an 
environmental cycle (free-living larvae). The parasitic cycle occurs when the infective 
filariform larvae penetrate the skin and secrete metalloproteases that facilitate penetration. 
The main larval route is via the bloodstream to the lungs, where they break into the alveolar 
spaces within hours after infection, promote haemorrhage, ascend the respiratory tree, are 
swallowed, and migrate to the intestine. Alternatively, the larvae may migrate directly 
through connective tissues (Grove, 1994, 1996). 
 
 
Fig. 1. Life cycle of Strongyloides stercoralis (modified from Carvalho & Da Fonseca Porto, 
2004, and http://emedicine.medscape.com/article/229312-overview#a0104). 
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The infective larvae reach the small intestine, where they moult twice to become female 
adult worms. These females reproduce in the absence of males by parthenogenesis. The 
females are embedded in the intestinal mucosa and produce eggs in the duodenum. The 
rhabditiform larvae emerge from the hatching eggs and migrate into the intestinal lumen, 
then pass into the external environment with the faeces. Depending on temperature and 
humidity, the rhabditiform larvae may have two different life cycles in the environment: an 
indirect (heterogonic) life cycle, in which the rhabditiform larvae differentiate into free-
living adults and release eggs that hatch and transform into infective larvae, or a direct 
(homogonic) life cycle, in which the rhabditiform larvae may moult directly into filariform 
larvae and repenetrate the host skin, restarting the cycle (Schad, 1989). 
One characteristic that differentiates S. stercoralis from almost all other worms is its capacity 
to replicate within the host. Rhabditiform larvae in the bowel lumen transform into 
filariform larvae before excretion and invade the intestinal wall or the perianal skin, 
permitting ongoing cycles of autoinfection, an important feature of strongyloidiasis (Concha 
et al., 2005).  
5. Clinical manifestation 
The clinical presentation of strongyloidiasis varies with the status of the host´s immune 
system, and the infection is classified as acute, chronic or severe. Acute infections of 
strongyloidiasis manifest as a wide spectrum of clinical features ranging from asymptomatic 
disease to cutaneous (larva currens and urticaria), pulmonary (cough and tracheal 
irritation), and gastrointestinal symptoms (diarrhoea and constipation), although the 
majority of S. stercoralis infections are resolved (Mahmoud, 1996).  
The ability of S. stercoralis to establish a cycle of autoinfection within the host results in 
chronic infections that can persist in an individual for decades. Chronic infections are often 
asymptomatic, but when symptoms occur they are usually mild, episodic and prolonged, 
including nausea, vomiting, diarrhoea, constipation, weight loss or cutaneous reactions 
(Grove, 1989).  
Uncontrolled autoinfection of S. stercoralis is more likely to occur in immunosuppressed 
patients, leading to hyperinfection syndrome. The pulmonary phase of hyperinfection due 
to migrating larvae resembles Löffler syndrome with coughing and wheezing, asthma-like 
symptoms, haemorrhaging and pneumonia. In the intestine, symptoms include diarrhoea, 
nausea, vomiting, abdominal pain, and weight loss (Concha et al., 2005; Viney & Lok, 2007). 
Bacteremia is a common complication of hyperinfection syndrome and is caused by 
filariform larvae that may lead bacteria from the bowel to the bloodstream with subsequent 
secretion into the host circulation (Bamias et al., 2010). Pathogens such as Streptococcus bovis, 
Escherichia coli, Klebsiella pneumonia or Enterobacter cloacae are found during fatal 
complications of strongyloidiasis (Link & Orenstein, 1999). The mortality rate of 
dissemination associated with bacterial infections can reach approximately 90% (Igra-
Siegman et al., 1981). 
Dissemination occurs upon larval migration to organs beyond the range of the pulmonary 
phase, such as the liver, heart, lymph nodes, gallbladder, kidneys, pancreas, and brain 
(Keiser & Nutman, 2004). Petechiae and purpura have also been reported in disseminated 
cases as a result of larval migration through vessel walls, which promotes haemorrhage 
(Basile et al., 2010). Others complications of disseminated strongyloidiasis can occur and 
include syndromes such as cholecystitis, pancreatitis, paralytic ileus, intestinal perforation 
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or infarction, peritonitis, and sepsis (Krishnan et al., 2006). Although unusual, brain 
involvement can occur in disseminated infections, with symptoms including headache, focal 
seizures, altered mental state, secondary bacterial meningitis and coma (Dutcher et al., 
1990).  
6. Hyperinfection syndrome 
Since 1966, studies have reported that autoinfection may result in the dissemination of 
worms; denoted hyperinfection syndrome, the number of worms increases significantly, and 
worms are detectable in extraintestinal regions, with a mortality rate above 80% (Siddiqui & 
Berk, 2001). High-risk factors for hyperinfection and dissemination include corticosteroid 
therapy, malignancies, transplantation, malnutrition, hypogammaglobulinemia, and viral 
infections such as HIV (Human Immunodeficiency Virus) and HTLV-1 (Human T- 
Lymphotropic Virus Type 1) (Concha et al., 2005). 
6.1 Corticosteroids 
In recent decades, hyperinfection syndrome has increased significantly with the use of 
immunosuppressive drug therapy. Corticosteroids are widely prescribed drugs with potent 
immunosuppressive effects and are a major risk factor for the transformation of chronic 
strongyloidiasis into hyperinfection, which has a higher index of mortality (Armignacco et 
al., 1989; Al Maslamani et al., 2009). Corticosteroids are involved in the treatment of several 
diseases that are considered immunological abnormalities, such as lymphoma, rheumatoid 
arthritis, leprosy, chronic obstructive pulmonary disease (COPD), and polymyositis, leading 
to fatal hyperinfection in many cases (Keiser & Nutman, 2004). 
However, the role of corticosteroids in susceptibility to severe S. stercoralis infection is 
poorly understood. One hypothesis is that both endogenous and exogenous corticosteroids 
promote immunosuppression by decreasing the number of inflammatory cells, such as 
eosinophils and mast cells, and suppressing the transcription of several cytokines. In 
addition, corticosteroids increase the apoptosis of Th2 lymphocytes (Genta, 1989). 
Corticosteroids may also have a direct effect on female worms by increasing the production 
of ecdysteroid-like molecules, hormones that control moulting in insects and possibly 
helminths (Genta, 1992). An increase in these molecules increases the moulting rate and 
transforms rhabditiform larvae into filariform larvae, increasing the worm burden and 
promoting hyperinfection and dissemination (Genta, 1992; Siddiqui et al., 2000).  
6.2 Hematologic and others malignancies 
Patients with hematologic malignancies have a high prevalence of S. stercoralis infection 
when compared with the global index. The reported cases of hematologic malignancies and 
S. stercoralis hyperinfection syndrome are associated with glucocorticoid treatment. The 
malignancy usually associated with S. stercoralis is lymphoma that is being treated with 
chemotherapy. Moreover, lung cancer has been associated with hyperinfection during the 
administration of immunosuppressive chemotherapy (Keiser & Nutman, 2004). 
6.3 Transplantation 
Hyperinfection syndrome is associated with transplants, and the progression of chronic 
intestinal infection before transplantation appears to be the most common mechanism. 
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Hyperinfection cases following organ transplant principally occur during the initial months 
after transplantation, but the infection was acquired before transplantation in the majority of 
cases (Roxby et al., 2009). Higher mortality rates occur from extraintestinal strongyloidiasis, 
which in most of these cases are related to corticosteroid therapy to treat rejection (Keiser & 
Nutman, 2004).  
Renal transplants are most commonly associated with hyperinfection, which is related to 
immunosuppressive treatments (Devault et al., 1990; Rajapurkar et al., 2007; Valar et al., 
2007). Cases of hyperinfection have been described in transplant recipients of other organs, 
such as the liver (Vilela et al., 2008; Rodrigues-Hernandez et al., 2009), heart (Schaeffer et al., 
2004), pancreas (Ben-Yousseff et al., 2005), lung (Balagopal et al., 2009), and intestine (Patel 
et al., 2008). Hyperinfection in hematopoietic stem cell transplant patients may be due to 
immunosuppressive therapies (Dulley et al., 2008; Wirk & Wingard, 2008). 
6.4 Malnutrition 
An important cause of immunodeficiency that is related to hyperinfection is malnutrition, 
particularly in developing countries. Malnutrition promotes disruption of the intestinal 
mucosa, impairing the host’s ability to expel the parasite from the gut (Olsen et al., 2009). 
6.5 Hypogammaglobulinemia 
Patients with immunodeficient conditions, such as hypogammaglobulinemia, may develop 
fatal hyperinfection. Case reports show that hypogammaglobulinemia is refractory to 
prolonged anthelmintic therapy (Brandt de Oliveira et al., 1981; Seet et al., 2005).  
6.6 HIV 
Although HIV infection predisposes a patient to hyperinfection due to immunosuppression, 
few cases of S. stercoralis and AIDS have been described (Marcos et al., 2008). The association 
between S. stercoralis and HIV principally occurs in endemic areas (Siddiqui & Berk, 2001). 
The hyperinfection syndrome can occur in patient with HIV with immune reconstruction 
syndromes increased after starting of highly active antiretroviral therapy (Brown et al., 
2006). On the other hand, the infection with Strongyloides may contribute to serious 
nutritional deficiencies in HIV-infected individuals, such as anorexia and malabsorption 
(Lindo et al., 1998). However, the immunobiological and immunoregulatory mechanisms 
involving HIV and strongyloidiasis remain unclear. 
6.7 HTLV-1 
HTLV-1 is a virus that infects T cells and induces lymphocyte proliferation with the 
production of a Th1-type immune response in humans. The genome of the HTLV-1virus is 
diploid and, following interaction with the immune system, HTLV-1 enables the 
transcription of the viral DNA by integrating into the host genome effectively evading 
immune surveillance without killing the host (Iriemenan et al., 2010). Strongyloidiasis is 
strongly associated with HTLV-1, which predisposes patients to severe infections by 
depressing cell-mediated immunity or IgE responses (Grove, 1996; Carvalho & Da Fonseca 
Porto, 2004). Strongyloides and HTLV-1 may promote the Th1-type response in patients, 
increasing interferon levels and decreasing Th2-type responses, such as interleukin 4 (IL-4), 
IL-5, IL-13, and IgE, important host defences against helminths, and a decrease in this 
response allows not only an increasing in autoinfection but also decreased parasite killing. 
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In addition, this association reduces the efficacy of anthelmintic drugs, increasing the 
prevalence of infection (Montes et al., 2009; Iriemenam et al., 2010). Stool examinations 
should be performed with special attention to detect S. stercoralis larvae in all patients 
infected by HTLV-1 (Carvalho & Da Fonseca Porto, 2004). 
7. Host-parasite interaction 
The relationship between S. stercoralis and its host is complex, and little is known about the 
immunomodulatory mechanisms that regulate this interaction. Different factors are 
involved, including the capacity of the parasite to replicate, the adequacy of the host 
immune response, and the ability of the parasite to evade those responses (Grove, 1994; 
Trajman et al., 1997). 
7.1 Cellular immune response 
During helminthic infection, Th2-type cell-dependent host defences that involve CD4 cells 
are developed (Maizels & Yazdanbakhsh, 2003; Anthony et al., 2007). In human hosts and 
animal models, the cellular immune response to Strongyloides infection is characterised by 
intraepithelial and tissue eosinophils, neutrophils and mast cells with Th2-type production 
of cytokines such as IL-4, IL-5 and IL-13. Conversely, Th1-type responses are down-
regulated during nematode infection (El-Malky et al., 2003; Paterson et al., 2008; Iriemenam 
et al., 2010).  
7.1.1 Eosinophils 
Eosinophils are essential against nonphagocytosable parasites, such as Strongyloides, that 
cannot be ingested because of their large size. Eosinophils defend the host by attacking the 
parasite via the FcεRI receptor, capturing antigens from the worms and presenting the 
antigens to T cells to initiate an antigen-specific immune response (Galioto et al., 2006; 
Padigel et al., 2006; Iriemenam et al., 2010). Others mechanisms may be involved, including 
antibody-dependent cellular cytotoxicity (ADCC) mediated by eosinophils on the parasite 
surface, which releases toxic molecules in an attempt to eliminate the parasite (Ligas et al., 
2003; Klion & Nutman, 2004). 
7.1.2 Mast cells 
Mast cells have an important role in the defence against S. stercoralis by inhibiting the 
invasion of the adult worm into the intestinal epithelium, promoting the stimulation of gut 
motility, mucus release and expulsion of the parasites. In addition, mast cells induce the 
attraction and modulation of eosinophils (Kobayashi et al., 1998; Concha et al., 2005).  
7.2 Cytokines 
Strongyloidiasis promotes the robust Th2-type immune response with the production of 
cytokines, such as IL-3, IL-4, IL-5, IL-6, IL-9, IL-10 and IL-13. Contrarily, Th1-type responses 
are reduced during nematode infection (Wilkes et al., 2007; Patel et al., 2009). 
IL-3 is important during Strongyloides infection stimulates the synthesis of potent mast cells 
and basophils enhancing the function of these cells (Abe et al., 1993). In addition, IL-3 can 
enhance the levels of intra-cellular IL-4 upon activating basophils, with anti-IgE and IL-3 
contributing to an increase in eosinophils (Kimura et al., 2006; Lantz et al., 2008). 
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IL-4 has multiple immunoregulatory functions, including T-cell growth factor activity, B-cell 
regulation, serum IgE level enhancement, and stimulation of the growth and/or 
differentiation of macrophages, hematopoietic cells, and mast cells (Urban et al., 1991; 
Negrão-Correa et al., 2006; Wilkes et al., 2007). IL-4 decreases the fecundity and survival of 
adult worms and increases intestinal smooth muscle contraction, facilitating the expulsion 
of the parasite (Concha et al., 2005).  
IL-5 regulates the production of eosinophil myelocyte precursors in bone marrow, the 
development of mature eosinophils after helminth infection and, in most instances, the 
production of a number of other cytokines, including IL-4 and IL-13, and chemokines such 
as RANTES and eotaxin (Herbert et al., 2000; Klion & Nutman, 2004; Mir et al., 2006).  
IL-13 also participates in the defence mechanisms against helminths, promoting an increase 
in the intestinal fluid content and increased smooth muscle contractility, a phenomenon that 
may contribute to worm expulsion (Porto et al., 2001; Shea-Donohue & Urban, 2004; Patel et 
al., 2009).  
7.3 Humoral immune response 
The humoral immune response complements defence mechanisms against strongyloidiasis 
with the production of immunoglobulins by plasma cells. Several immunoglobulins, such as 
IgE, IgG and IgM, are essential for the elimination of the parasite (Ligas et al., 2003; 
Machado et al., 2005).  
IgE antibodies can mediate the activation of accessory cells and the recognition of parasite 
antigens, promoting goblet cell mucus secretion and the degranulation of mast cells that 
release mediators affecting parasite survival (Machado et al., 2009). IgG and IgM can 
transfer immunity against the human parasite in the presence of the complement system 
and neutrophils (Abraham et al., 1995; Vadlamudi et al., 2006)  
Laboratory models have suggested that both T and B cells mediate the immune response 
through an increase in immunoglobulins, eosinophils and mast cells and hyperplasia of 
goblet cells, which require interleukins and chemokines for their development and 
activation. In strongyloidiasis, dexamethasone seems to primarily suppress cytokines such 
as IL-1ǃ, IL-4, VEGF, TNF-ǂ, IFN-Ǆ, IL-3, IL-4, IL-5, IL-10 and IL-12 and decreases the 
production of IgG and IgE antibodies during S. venezuelensis infection (Machado et al., 2011; 
Tefé-Silva et al., 2012).  
7.4 Other responses 
The complement system activates both classical and alternative pathways with 
chemoattraction and binding of granulocytes in association with effector cells, which are 
essential against S. stercoralis (Vadlamudi et al., 2006). Studies have reported that complement 
component C3 is required during S. stercoralis infection and facilitates eosinophil 
degranulation and larval death during the innate immune response (Kerepesi et al., 2006). 
Strongyloides infection induces the production of leukotrienes, which are required to invoke 
the protective expulsion of parasites. Leukotrienes play an important role in controlling 
parasite burdens, as well as in altering the parasite reproductive cycle and eliminating the S. 
venezuelensis parasite (Machado et al., 2005). 
8. Pathology 
The pathology of strongyloidiasis differs in different stages of infection. 
www.intechopen.com
 
Current Topics in Tropical Medicine 
 
384 
8.1 Acute infection 
The obligate pulmonary phase of the parasite’s life cycle typically occurs within hours after 
infection. During larval passage through the lungs, the parasite induces haemorrhage in the 
alveolar spaces, inflammatory infiltrate, and, occasionally, granuloma (Kinjo et al., 1998).  
Histopathological analyses of human intestines have shown that S. stercoralis eggs and adult 
females colonise the duodenum and upper jejunum. Studies have also demonstrated the 
presence of oedema, duodenal villous atrophy, and crypt hyperplasia with disrupted 
epithelium due to the inhibition of cell proliferation and apoptosis (Coutinho et al., 2006; 
Werneck-Silva et al., 2006). Surface damage, ulceration, an increase in mucus secretion and 
functional changes in the intestine have also been reported. In many cases, the eosinophil 
infiltrates are associated with the intensity of the infection (Rivasi et al., 2006; Kishimoto et 
al., 2008).  
8.2 Hyperinfection syndrome 
The histology of lungs affected by hyperinfection syndrome revealed alveolar haemorrhage 
with large numbers of larvae in the alveoli, septa, pleurae and blood vessels. Many larvae 
were present throughout the walls of the tracheobronchial tree, with an increase in number 
toward the upper respiratory tract. Larvae in the lungs provoked inflammatory infiltrate  
 
 
Fig. 2. Histopathology of Strongyloides stercoralis in the lungs and intestine of a 48-year-old 
woman with a gastric carcinoid tumor treated with chemotherapy. A and B: Pulmonary 
parenchyma. Note the presence of larvae in alveolar space (arrow). C and D: Female worms 
in the duodena (arrows). HE stain. 
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and were occasionally walled off by granulomas. Bronchopneumonia is probably a 
consequence of tissue damage inflicted by the invading larvae (Zumla & James, 2002). 
In the human intestine, hyperinfection results in mucosal oedema, acute inflammation, 
mucosal haemorrhage, and focal ulceration with numerous S. stercoralis larvae, adult worms 
and ova embedded within the small bowel villi (Sathe &Madiwale, 2006; Al Maslamani et 
al., 2009).  
  
 
Fig. 3. Histopathology of the lungs of rats in an experimental model of strongyloidiasis on 
day 3 post-infection: A and B: Controls; C and D: Infected with S. venezuelensis. Note the 
scarce hemorrhagic foci with larvae in the alveolar spaces (arrows); E and F: Infected with S. 
venezuelensis and treated with dexamethasone. Note the prominent hemorrhagic foci 
showing larvae in the alveolar spaces (arrow). HE stain. 
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8.3 Hyperinfection syndrome in experimental models 
Animal models are important for understanding the mechanism of hyperinfection. Studies 
in experimental models of S. venezuelensis infection have reported that filariform larvae were 
surrounded by inflammation mediated by eosinophils and mast cells in the lungs. The 
infection also promoted an important granulomatous response, sometimes entrapping the 
larvae, which is probably an attempt by the host to contain the parasite. In addition, airway 
 
 
Fig. 4. Histopathology of the duodena of rats in an experimental model of strongyloidiasis 
on day 14 post-infection: A and B: Controls; C and D: Infected with S. venezuelensis. E and F: 
Infected with S. venezuelensis and treated with dexamethasone on day 14 post-infection. 
Note the massive mucosal invasion of fertile eggs and adult parasites, accompanied by 
erosion of the intestinal epithelial layer. HE stain. 
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remodelling similar to asthma, characterised by hyperplasia of goblet cells and increased 
bronchiolar wall thickness caused by oedema, hypertrophy of smooth muscle cells, 
neovascularisation and collagen deposition, was reported. In contrast, immunosuppression 
with dexamethasone interferes with the pulmonary cycle of Strongyloides venezuelensis 
infection and promotes greater haemorrhage, which is provoked by the substantial 
quantities of larvae that pass into the alveolar spaces, accompanied by a decrease in 
eosinophil and mast cell migration and impaired formation of granulomas (Tefé-Silva et al., 
2008). In addition, dexamethasone treatment inhibited airway remodelling, contributing to 
the dissemination of the parasite (Tefé-Silva et al., 2012). 
In the small intestine of rodents infected with S. venezuelensis, females and fertile eggs were 
observed in the wall of the gastrointestinal tract and invading the intestinal mucosa, with 
increased inflammatory exudate and eosinophils (Machado et al., 2005). Dexamethasone 
treatment promoted increased mucus production, which progressed to a massive mucosal 
invasion of fertile eggs and adult parasites that was accompanied by the erosion of the 
intestinal epithelial layer. Interestingly, the inflammatory response was relatively 
inconspicuous. Proliferative activity increased in the crypts and the villous fusion, resulting 
in an apparent reduction in the number of intestinal epithelial cells. In addition, 
dexamethasone enhanced parasite fertility and proliferation, with dissemination of the 
larvae to other visceral organs, such as the spleen, kidneys, heart, liver and brain (Machado 
et al., 2011).  
Mice infected with S. venezuelensis and treated with dexamethasone showed increased blood 
neutrophil numbers and a reduction in eosinophil and mononuclear cell numbers in the 
blood, bronchoalveolar cells, and peritoneum when compared to S. venezuelensis infection 
in the absence of dexamethasone. In addition, dexamethasone impaired the host immune 
response, decreasing the production of cytokines such as tumour necrosis factor (TNF), 
interferon (IFN), interleukin-3 (IL-3), IL-4, IL-5, IL-10, and IL-12 in the lungs and circulating 
antibodies such as IgG, and IgE but increasing the overall parasite burden in the intestines 
and faeces (Machado et al., 2011). 
9. Diagnosis  
Strongyloidiasis is diagnosed on the basis of suspicion in patients with clinical signs and 
symptoms of the disease; however, in approximately 50% of cases, the infection is 
asymptomatic, complicating diagnosis. In some cases, diagnosis is difficult despite a low 
intestinal worm load and larval excretion in the faeces (Rajapurkar et al., 2007). 
The classic triad of urticaria, abdominal pain and diarrhoea is suggestive of a diagnosis of 
strongyloidiasis. Parasites are usually found in the faeces; they are sometimes also seen in 
other body fluids or in tissue samples (Basile et al., 2010). The parasitological diagnosis is 
usually made after an examination of the faeces, and several diagnostic methods can be used 
to detect S. stercoralis, including stool examination, a modified Baermann technique, and 
stool culture on a blood agar plate. Enzyme-linked immunosorbent assays (ELISA) are used 
for serological diagnosis and have proven valuable in detecting both symptomatic and 
asymptomatic strongyloidiasis infection, with a high specificity for detecting IgG antibodies 
to S. stercoralis (Basile et al., 2010). 
In patients with a disseminated infection, the diagnosis is relatively straightforward, given 
the high numbers of larvae that exist in the stool and, usually, in the sputum. White blood 
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cell numbers may be elevated. Although an increase in eosinophils frequently occurs during 
infection, studies have shown that an absence of eosinophilia does not exclude a diagnosis 
of strongyloidiasis (Krishnan et al., 2006). Diagnosis through imaging is usually possible. 
Chest radiographs of some patients have shown infiltrate consistent with Loeffler’s 
syndrome. Methods such as bronchoalveolar lavage and sputum culture are used to 
diagnose disseminated strongyloidiasis (Williams et al., 1988, Yassin et al., 2010). Duodenal 
fluid aspiration and intestine biopsy or the use of Enterotest ® may be required to detect the 
Strongyloides parasite (Yassin et al., 2010).  
10. Treatment 
Early identification of the disease and anthelminthic treatment results in a better prognosis 
for strongyloidiasis and, in many cases, prevents a fatal infection (Basile et al., 2010). S. 
stercoralis is resistant to anthelmintic drugs, and the parasite has the capacity to replicate and 
increase the worm burden again (Grove, 1996).  
Thiabendazole, albendazole, and mebendazole are effective drugs against S. stercoralis. 
Thiabendazole was the drug of choice for treatment of strongyloidiasis, with a cure rate of 
up to 80%. Albendazole has variable therapeutic efficacy but has been used in 
hyperinfection syndrome and remains a viable treatment alternative to ivermectin. 
Mebendazole can be used to treat strongyloidiasis but is not recommended because of an 
association with liver dysfunction (Rajapurkar et al., 2007). Recently, there has been a 
change in the treatment of strongyloidiasis, as more studies support the choice of the drug 
ivermectin, which is effective at killing worms in the intestine. In patients with 
hyperinfection syndrome, ivermectin is considered the first-line therapy, and longer courses 
of treatment are indicated (Roxby et al., 2009). 
Efficient treatment of strongyloidiasis depends on several factors that can decrease the 
efficacy of the drugs used for treatment, such as immunodeficiency, corticosteroid use, or 
co-infection with HTLV-1 (Vadlamudi et al., 2006). Prolonged or repeated treatment may be 
required in patients receiving immunosuppressive drugs. 
Other measures, including decreasing the dosage of corticosteroids, discontinuing 
immunosuppressive therapies and treating bacterial infections, are essential elements in the 
treatment of these patients. In all cases, patients with strongyloidiasis, regardless of the severity 
of symptoms, must be treated to prevent long-term complications (Montes et al., 2010). 
11. Control 
Like other soil-transmitted nematode infections, strongyloidiasis can be controlled by 
improving sanitary conditions and properly disposing of faeces. Infected patients should be 
treated, even if they are asymptomatic, to preclude the possible onset of autoinfection. 
Immunosuppressants are contraindicated in these patients. Personal hygienic measures like 
proper protection of the skin to prevent contact with infected soil, community education 
about protective and hygienic measures, and prompt treatment of diagnosed cases would 
help prevent the disease (Vadlamudi et al., 2006). 
12. Conclusion 
Strongyloidiasis is an infection with a tendency to become chronic with an indolent course. 
However, in immunocompromised patients, especially those treated with corticosteroids, 
www.intechopen.com
 
Hyperinfection Syndrome in Strongyloidiasis 
 
389 
hyperinfection syndrome can compromise the prognosis of the patient. The mortality rates 
of hyperinfection are high, making Strongyloides infection an important global health 
problem. It is important to understand the biology and immunology of infection with S. 
stercoralis and the altered courses of infection that may occur when immune regulation is 
compromised. Clinicians who are aware of the possibility of hyperinfection are better 
equipped to diagnose, treat, or altogether prevent the fatal consequences of this lethal 
nematode. 
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